How Investors May Respond To Warrior Met Coal (HCC) Launching Its US$1 Billion Blue Creek Mine

Warrior Met Coal, Inc. +3.25%

Warrior Met Coal, Inc.

HCC

94.89

+3.25%

  • Warrior Met Coal, Inc. recently completed its approximately US$1.00 billion Blue Creek Mine in Alabama, a longwall operation expected to produce an average of 6.0 million short tons of metallurgical coal annually over its first decade while adding more than 300 local jobs and integrated rail and barge logistics.
  • Coupled with newly awarded federal coal leases expected to support more than 40 years of mining and over 500 additional jobs, these moves materially expand Warrior Met Coal’s access to one of North America’s largest untouched steelmaking coal reserves and reshape the scale of its operations.
  • Next, we’ll examine how bringing Blue Creek online at scale could influence Warrior Met Coal’s investment narrative built around cost leadership.

We've found 12 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Warrior Met Coal Investment Narrative Recap

To own Warrior Met Coal, you need to be comfortable with a concentrated bet on metallurgical coal for steelmaking, where pricing and volume are heavily tied to global steel demand. The Blue Creek completion and new federal leases reinforce the long term production story, but in the near term the key catalyst remains how quickly Blue Creek ramps commercially, while the biggest risk is layering this new capacity onto a market that may not absorb the extra tons at attractive prices.

The most relevant near term announcement is Warrior Met Coal’s upcoming Q4 2025 results and conference call on February 12, 2026, which should offer the first detailed update on Blue Creek’s commissioning progress and early cost profile. For investors watching the cost leadership narrative, that call may be important for assessing whether Blue Creek helps offset pressures from weaker price realizations and a higher mix of lower margin volumes.

Yet investors should be aware that the enlarged production base could amplify exposure to any prolonged softness in met coal pricing and steel demand...

Warrior Met Coal's narrative projects $2.0 billion revenue and $636.5 million earnings by 2028.

Uncover how Warrior Met Coal's forecasts yield a $80.83 fair value, a 19% downside to its current price.

Exploring Other Perspectives

HCC Earnings & Revenue Growth as at Jan 2026
HCC Earnings & Revenue Growth as at Jan 2026

Four members of the Simply Wall St Community currently place Warrior Met Coal’s fair value between US$80.83 and US$168.94 per share, showing how far views can spread. You can weigh those against the risk that adding Blue Creek’s capacity into a weak pricing backdrop may pressure margins and free cash flow, with clear implications for how the business performs through the cycle.

Explore 4 other fair value estimates on Warrior Met Coal - why the stock might be worth 19% less than the current price!

Build Your Own Warrior Met Coal Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Warrior Met Coal research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Warrior Met Coal research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Warrior Met Coal's overall financial health at a glance.

Contemplating Other Strategies?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

  • AI is about to change healthcare. These 109 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
  • The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.